ARK Genomic Revolution ETF vs Tencent Music Entertainment Group - ADR — how do they compare? ARK Genomic Revolution ETF trades at $41.28, while Tencent Music Entertainment Group - ADR trades at $8.88 (market cap $14.63B). The key difference: Tencent Music Entertainment Group - ADR pays a 2.7% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Tencent Music Entertainment Group - ADR nearer its low. Which is the better fit depends on your goals.
| ARKG | TME | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $26.36 |
52-Week Low | $23.09 | $8.16 |
Market Cap | — | $14.63B |
Enterprise Value | — | $11.41B |
Dividend Yield | — | 2.7% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TME trades at $8.88, up 0.34% today, with a bullish technical signal despite recent earnings misses. The stock shows strong fundamentals with a P/E of 10.63 and net income margin of 26.48% for 2025. Revenue grew to $32.90B in 2025, though Q2 2026 EPS is expected at $0.24. Analyst consensus is mixed with a $14.00 price target. Recent news highlights strategic moves like the Ximalaya acquisition and partnerships, though competition remains a concern.
The outlook for TME is cautiously optimistic with solid profitability and valuation support, but near-term growth faces headwinds from competition and AI-related challenges. Investors should weigh the attractive margins against execution risks and market sentiment shifts for balanced exposure.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →